FFS
BIIB icon

Founders Financial Securities’s Biogen BIIB Stock Holding History

Founders Financial Securities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-707
Closed -$245K – 262
2021
Q2 		$245K Buy
+707
New +$214K 0.05% 257
2020
Q2 		– Sell
-1,273
Closed -$403K – 174
2020
Q1 		$403K Buy
1,273
+22
+2% +$6.68K 0.15% 79
2019
Q4 		$371K Buy
+1,251
New +$347K 0.13% 88

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Founders Financial Securities's BIIB Position: Q3 2021 in Review

Founders Financial Securities sold out of Biogen (BIIB) in Q3 2021, closing a stake of 707 shares — an estimated $245K sold.

Founders Financial Securities first reported a position in BIIB in Q4 2019 and held it in 3 quarters. The position peaked at $403K in Q1 2020. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Founders Financial Securities reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Founders Financial Securities sold 707 Biogen shares in Q3 2021, an estimated $245K.
  • Founders Financial Securities first reported a position in Biogen in Q4 2019 and held it in 3 quarters.
  • Founders Financial Securities's Biogen position peaked at $403K in Q1 2020.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Founders Financial Securities's 13F filing for Q3 2021, filed 15 Nov 2021.